• Tuesday, February 23, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST)
  • Thursday, February 25, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST)


Online, using zoom.us and live on Youtube


3D cell culture systems have recently as promising tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding extracellular matrix (ECM). Join us for this webinar to know more about BIOMIMESYS® technology, our 3D cell culture system designed for the physiologically-relevant culture of liver, brain, adipose tissue, and cancer cells in dedicated BIOMIMESYS® hydroscaffolds. Each matrix is characterized by its specific composition and stiffness, to be in accordance with in vivo conditions.

In this first webinar, Elodie Vandenhaute (PhD, in vitro cell culture expert in HCS Pharma) will explain the unique features of BIOMIMESYS® and highlight its use for organ-specific 3D cell culture with key examples of phenotypic characterization of cells in each matrix.

Learning objectives

  • Understanding the difference between 3D cell culture systems
  • Utilizing a relevant 3D cell culture platform for liver, brain, adipose tissue, and disease modeling (human cells) using BIOMIMESYS®

Registration ended but find the presentation below

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.